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Abstract
This study is an analysis of a workplace diabetes management program offered to employees of a Fortune 100
financial services corporation located in the United States. The 12-month worksite-based educational program
was for employees whowere at risk for diabetes, had prediabetes, or were diagnosedwith diabetes. This employed
population, with health benefits, generally had acceptable control of their diabetes at the start of the program.
They statistically improved most self-efficacy measures, but improvement in biometric tests at 6 and 12 months
were not significantly different from baseline. Mean hemoglobin A1c at baseline, 6 months, and 12 months was
7.2%, 7.2%, and 7.3%, respectively. At 12 months, about 40% of preprogram survey participants completed all
screenings and the post-program questionnaire. Disease management programs at the workplace can be an
important component in helping employees enhance their knowledge of diabetes and maintain and improve their
health. (Population Health Management 2015;18:429–436)
Introduction
D iabetes mellitus (DM) affects an estimated 25.8million Americans or about 8.3% of the US population.1
About 1.9 million Americans aged 20 years or older were
newly diagnosed with diabetes in 2011. Another 35% of
adults in the United States aged 20 years or older had pre-
diabetes. As a result, an estimated 79 million Americans age
20 and older have prediabetes. Diabetes affects the working
age population with an estimated diagnosed and undiagnosed
diabetic population of 3.7% aged 20–44 and 13.7% aged 45–
64. The estimated direct and indirect costs of diabetes in the
United States were $174 billion, including $116 billion in
direct costs and $58 billion in indirect costs for disability,
work lost, and premature mortality (in 2007 dollars). A re-
analysis of data estimated that the burden of diabetes and
prediabetes was $218 billion in 2007 including $153 billion
in medical costs and $65 billion in lost productivity.2,3
It is projected that the prevalence of diabetes will increase
another 64% between 2010 and 2025, in large part attribut-
able to the epidemic of obesity in the United States.4,5 This is
hypothesized to result in 53 million people with diabetes and
annual medical and productivity costs of $500 billion.
Therefore, because diabetes is affecting a growing number of
working-age adults, a new role for worksite occupational
medicine clinics is disease management of chronic medical
conditions such as diabetes.6,7
A number of studies have generally demonstrated the
value of lifestyle interventions in the prevention and man-
agement of diabetes.8,9 An exception is one study of a
lifestyle intervention that focused on weight loss in people
with diabetes that showed no reduced risk of cardiovascular
disease in overweight and obese persons for these people.10
Diabetes self-management education is recommended for
all people with prediabetes and diabetes. Such education can
lead to the prevention or at least the delayed onset of dia-
betes and a reduction in the risk of complications from
diabetes. National guidelines have been established for self-
management education for people with diabetes.11 Never-
theless, studies have shown that the majority of people with
diabetes and prediabetes do not receive formal diabetes
education.12,13 There have been very few reports of work-
site-based diabetes management programs.14,15 The current
study documents the effort of a worksite diabetes education
program and its initial outcomes, which include comparison
of preprogram and post-program surveys as well as results
from baseline, 6-month, and 12-month biometric screenings.
Methods
Study population
This is a prospective analysis of a longitudinal cohort of
employees from a multinational Fortune 100 financial ser-
vices corporation based in the United States. This
1University of Illinois at Chicago, Chicago, Illinois.
2American Express Company, New York, New York.
3University of Michigan Health Management Research Center, Ann Arbor, Michigan.
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corporation has approximately 26,000 employees at multiple
sites in the United States.
The corporation has a global well-being program that fea-
tures best-in-class resources, enhanced access to care, and a
supportive work environment. The program goals are to im-
prove employee health and business productivity/performance,
and to control long-term health and productivity costs.
Approximately 65% of this corporation’s employees self-
reported at least 1 chronic health condition on their 2013
health risk appraisal (HRA). Approximately 5% of em-
ployees reported having diabetes on the 2013 HRA. In 2012,
medical and pharmacy costs for an employee with diabetes
were $9340 in contrast to $4447 for an employee without
diabetes. There were additional costs related to absenteeism,
disability, and decreased on-the-job productivity (pre-
senteeism) for the population with diabetes.
There are many barriers to chronic health condition man-
agement for employees. They include: provider lack of time,
lack of qualified health education providers in health care pro-
vider offices, poor implementation of disease management
guidelines by health providers, fragmentation of the health care
system, and lack of reimbursement benefits for health education.
In an effort to eliminate those barriers, the corporation
launched the Healthy Living with Diabetes program in
2012. The goals of the program were to:
 Educate employees on the value and importance of
diabetes management
 Provide employees with information to enhance dia-
betes self-care
 Provide a systematic approach to improving diabetes
outcomes
 Develop sustainable engagement in the employee’s
management of diabetes
In 2012, the Healthy Living with Diabetes program was
offered at all 6 worksite Health and Wellness Centers
(‘‘worksite clinics’’) across the United States. The on-site
health clinics serve between 400 and 4000 employees and
reach approximately 50% of the total US employee popu-
lation of this corporation. Depending on the size of the
employee population, these clinics are staffed by physicians/
nurse practitioners, occupational health nurses, a health
coach, and/or a dietitian, and an employee assistance pro-
gram (EAP) counselor. A communication plan was devel-
oped for the Healthy Living with Diabetes disease
management program that consisted of creative logos and
taglines used to invite employees with diabetes and predi-
abetes to opt into the program. Graphics including gummy
bears and the tagline, It’s not just about the sugar, were used
as a friendly, nonthreatening approach to diabetes manage-
ment. Communications were posted on the company’s in-
tranet, and flyers and posters advertising the program were
placed in all the Health and Wellness Centers and other
public areas. There was no targeted mailing or identification
of employees with diabetes based on a questionnaire or
health screening other than some tailored communications
to populations at increased risk for diabetes, including Af-
rican Americans and Hispanics, which were sent through a
partnership with employee diversity networking groups.
Various incentives were offered for program participa-
tion. For example, employees received a backpack with
diabetes educational materials and a free glucometer (One
Touch Ultra and One Touch Mini; Lifescan, Inc., a Johnson
& Johnson company, Milpitas, CA) with a starter supply of
glucose test strips, no-cost biometric screenings, wellness
raffles, $25 debit cards for completing 6-month and 12-
month biometric testing, and access to a comprehensive
range of resources to meet the program goals.
Participants were self-selected members of the employee
wellness center and were recruited through wellness center
flyers, posters, and internal advertising (ie, staff, E-posters,
Web site), and at screenings. Employees with both type 1 and
type 2 DM, those at risk for diabetes, and employees with
prediabetes were encouraged to enroll in this program. Parti-
cipants completed a registration questionnaire and baseline
biometric screenings. The questionnaire included a brief
medical history including questions about current treatment of
their diabetes and behavioral health questions including the
Patient HealthQuestionnaire 2 (PHQ-2) depression screener.16
Biometric screening includedmeasurements of blood pressure;
height, weight, andwaist circumferencemeasurements; fasting
venousblood specimens for lipid levels (total cholesterol, high-
density lipoprotein cholesterol, calculated low-density lipo-
protein (LDL) cholesterol, and triglycerides), blood glucose,
and hemoglobinA1c (HbA1c). Follow-up biometric screenings
were offered at 6months into the program and at the conclusion
of this 12-month program. Participants also were asked to
complete the post-program questionnaire at the end of the pro-
gram.Thepost-programquestionnaire asked the samequestions
as the preprogram questionnaire, with additional questions re-
lated to program evaluation. Of the initial 250 employees who
signed up for the program, 230 completed the preregistration
survey, 196 participated in at least 1 biometric screening, and
101 employees completed both the preprogram and post-pro-
gram surveys. Among those who completed both surveys, 69
also completed all 3 laboratory tests at baseline, 6 months, and
12months. This study is focused on those 101 participants who
answered both preprogram and post-program questionnaires.
During the program year, participants had access at no
cost to a multidisciplinary team of worksite clinic staff for
one-on-one consultations. The team includes a registered
nurse or nurse practitioner, health coach, dietitian, phar-
macist, and EAP counselor. Group classes were presented
by a certified diabetic health educator, dietitian, and con-
sulting pharmacist from the corporation’s Pharmacy Benefit
Manager. An EAP counselor was available in each worksite
clinic and behavioral health education also was available via
webinars, which were recorded and available for later re-
play. Topics covered in group classes or webinar series in-
cluded: What is Diabetes, Carbohydrate Counting and
Maintaining a Healthy Diet, Exercise and Diabetes, Dia-
betes Medication Management, and Dealing with a Chronic
Condition at Work and Home. To keep participants en-
gaged, technology tools, including educational e-mails with
Web site links, were used as touch points every 2 weeks,
along with prize raffles for participation in group classes or
webinar presentations.
Results
Demographics
Demographics and diabetes status of the study partici-
pants are presented in Table 1. A total of 101 employees
participated in the program and completed preprogram and
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post-program questionnaires in the Diabetes Education
Program (Table 1).
After the program, more participants were under the care of a
health care provider, with the ‘‘no provider’’ response declining
from 16.8% to 10.9% and a corresponding increase in care by a
generalist or specialist and a decline in care by ‘‘other’’ provider.
Biometric testing
Although follow-up biometric tests were offered to all
participants, not everyone completed all 3 tests. Of the 101
who completed both surveys, 69 participated in all 3 bio-
metric screenings at baseline, 6 months, and 12 months.
Table 1 shows these 3-time screening participants were
similar to the survey completers in terms of sex, age, and
ethnicity. Work location and remote working status did in-
fluence the screening participation.
Among the 65 diabetic employees, 40 (61.5%) completed
all 3 biometrics screenings. Among the 34 employees who
had prediabetes or were at risk for diabetes, 28 (82.4%)
completed all 3 biometric tests at baseline, 6 months, and 12
months. Table 2 shows both the test values and percentage
of people who reached various biometric goals set by the
American Diabetes Association17 for those with prediabetes
or found to be at high risk for diabetes on the preprogram
survey. Table 3 shows the same information for employees
who had diabetes on the preprogram survey. What is evident
from the baseline testing in both groups is how well, in
general, they remain in good control of their DM. Although
the observed changes did not reach statistical significance,
all measured items showed either maintenance or slight
improvement.
The mean HbA1c level of employees with diabetes was
7.2% at baseline, 7.2% at 6 months, and 7.3% at 12 months
(Table 3). Mean LDL-cholesterol levels were all within the
normal limits. Only the mean body mass index was abnor-
mal at baseline, 6 months, and 12 months.
Among employees classified as having prediabetes or
being at high risk for diabetes, the mean HbA1c, systolic
and diastolic blood pressure, and lipid levels were, on av-
erage, normal. The percentage of participants with an
HbA1c < 7% declined from 96.4% at baseline and 6 months
to 85.7% at 12 months.
Knowledge of diabetes
Questions were asked at pre program and post program to
determine participant knowledge of diabetes and its man-
agement (Fig. 1). Overall self-reported understanding of
diabetes care increased (good, very good, or excellent)
significantly from 70.3% to 94.1% (P < 0.0001). Ability to
cope with stress increased from 69.3% to 84.2%
(P= 0.0035), knowledge of the understanding of diet for
blood sugar control increased from 70.3% to 82.2%
(P= 0.0455), the role and importance of exercise in diabetes
care increased from 73.3% to 89.1% (P = 0.0007), and un-
derstanding of diabetes medications increased from 69.3%
to 92.1% (P = 0.0002). Understanding of blood glucose
monitoring increased from 66.3% to 90.1% (P < 0.0001),
and understanding of how diet, exercise, and medications
affect blood glucose levels increased from 73.3% to 91.1%
(P= 0.0002). Similarly there was a statistically significant
increase in knowledge of the prevention and treatment of
high blood glucose (P < 0.0001), low blood glucose
(P< 0.0001), prevention of long-term complications of dia-
betes (P < 0.0001), foot care (P< 0.0001), and benefits of
improving blood glucose control (P < 0.0001).
Diabetes care
In contrast to the statistically significant changes in the
knowledge of diabetes, there were generally no statistically
significant changes in diabetes biometrics and control.
These results are summarized in Figure 2. Participants
Table 1. Demographics and Diabetes Status
of Study Participants at Baseline
Participants
of both pre
and post
surveys
Also participated
all 3 biometric
screenings
n = 101 % n= 69 %
Average Age 49.0 years 48.8 years
Sex
Male 31 30.7% 22 31.9%
Female 70 69.3% 47 68.1%
Location*
Arizona 38 37.6% 29 42.0%
Utah 11 10.9% 6 8.7%
Florida 36 35.6% 18 26.1%
New York 16 15.8% 16 23.2%
Work remotely*
All of the time 12 11.9% 5 7.3%
Some of the time 40 39.6% 29 42.0%
Never 49 48.5% 35 50.7%
Ethnicity
White 52 51.5% 35 50.7%
Black 16 15.8% 10 14.5%
Asian or Pacific
Islander
13 12.9% 11 15.9%
Hispanic 10 9.9% 6 8.7%
Other/No response 10 9.9% 7 10.2%
Has your doctor told you that you have.*
Diabetes 65 64.4% 40 58.0%
Prediabetes 21 20.8% 17 24.6%
Elevated blood
glucose
4 4.0% 4 5.8%
Increased risk factors
for diabetes
9 8.9% 7 10.1%
None of the Above 2 2.0% 1 1.5%
How long have you had diabetes?*
No diabetes or
prediabetes
31 30.7% 24 34.8%
1–12 months 9 8.9% 5 7.3%
13–60 months 27 26.7% 15 21.7%
6–10 years 23 22.8% 19 27.5%
11 years or longer 11 10.9% 6 8.7%
Who currently provides your main diabetes care?
Generalist 60 59.4% 39 56.2%
Specialist 19 18.8% 15 21.7%
Other 5 5.0% 3 4.5%
No one or not
applicable
17 16.8% 12 17.4%
*P < 0.05, McNemar’s Test, compared to overall participants
population.
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generally report increased blood glucose testing (P =
0.0105); however there was no significant change in the
number of times they experienced either low or high blood
glucose in the past month. Although the percentage of
employees reporting exercising 3 or more times per week
increased from 44.6% to 53.5%, the increase was not sta-
tistically significant (P = 0.1282). Fewer participants re-
ported that diabetes kept them from normal activities,
although the difference was not statistically significant.
Fewer participants reported that paying for diabetes treat-
ment was a problem and decreased at baseline from 72.3%
to 57.4% at 12 months (P = 0.0122).
Instructed to have following a meal plan both statistically
improved from pre program to post program (P = 0.0004 and
P = 0.0027, respectively) (Fig. 2). Participants were more
likely to perform a foot examination regularly after the
program, 63.4% vs. 79.2% (P= 0.0017).
There was no significant change in the last time partici-
pants had HbA1c or cholesterol testing; however almost
90% of participants report having these tests in the past 6
months. It is important to note that several participants had
prediabetes or were at risk for diabetes, in which case lab-
oratory tests generally are not routinely indicated every 6
months. There was no significant change in the use of
medications including insulin or in reported complications
of diabetes such as hypertension and cardiovascular disease
from baseline to 12 months.
Diabetes and self-reported outcomes
Preprogram general health was described as good, very
good, or excellent by 79.2% of participants at baseline and
by 85.1% (P = 0.0833) at post program, which is considered
borderline statistically significant.
Table 2. Pre- and Post-Program Survey Participants with Baseline, 6-Month, and 12-Month
Biometrics Measures: Prediabetes/At Risk for Diabetes
Prediabetes/At Risk for Diabetes at Baseline (n = 28 out
of 34 with prediabetes or at risk at baseline)
Means % Reached Goals
Baseline 6 months 12 months Goal17 Baseline 6 months 12 months
Glucose (mg/dL) 104.4 103.7 105.3 £ 100mg/dL 53.6% 46.4% 50.0%
HbA1c (%) 6.0 5.9 5.9 < 7.0% 96.4% 96.4% 85.7%
SBP (mmHg) 121.1 120.3 122.9 140/90mmHg 78.6% 85.7% 75.0%
DBP (mmHg) 80.9 79.5 77.4
Total Cholesterol (mg/dL) 177.0 175.0 176.2 < 200mg/dL 78.6% 82.1% 78.6%
LDL (mg/dL) 101.3 101.6 98.5 < 100mg/dL 50.0% 53.6% 57.1%
HDL (mg/dL) 46.7 47.0 50.3 M, > 40mg/dL F, > 50mg/dL 42.9% 57.1% 53.6%
Triglycerides (mg/dL) 145.3 131.9 137.0 < 150mg/dL 64.3% 71.4% 64.3%
Weight (lbs) 204.4 204.3 203.1
BMI (kg/m2) 32.1 32.6 32.2 < 30 kg/m2 42.9% 39.3% 39.3%
Waist Circumference (in) 40.1 39.9 40.5 M, £ 40 inches F, £ 35 inches 35.7% 35.7% 35.7%
BMI, body mass index; DBP, diastolic blood pressure; F, female; HDL, high-density lipoprotein cholesterol; in, inches; LDL, low-density
lipoprotein cholesterol; M, male; SBP, systolic blood pressure.
Table 3. Pre- and Post-Program Survey Participants with Baseline, 6-Month, and 12-Month
Biometric Measures: With Diabetes
Diabetes at Baseline (n = 40 out of 65 people with diabetes at baseline)
Means % Reached Goals
Baseline 6 months 12 months Goal17 Baseline 6 months 12 months
Glucose (mg/dL) 140.5 146.9 152.6 £ 100mg/dL 17.5% 17.5% 12.5%
HbA1c (%) 7.2 7.2 7.3 < 7.0% 60.0% 65.0% 47.5%
SBP (mmHg) 131.7 130.5 130.9 140/90mmHg 65.0% 60.0% 57.5%
DBP (mmHg) 83.5 80.6 81.4
Total Cholesterol (mg/dL) 171.8 172.5 169.2 < 200mg/dL 90.0% 80.0% 80.0%
LDL (mg/dL) 90.0 94.5 88.8 < 100mg/dL 67.5% 60.0% 67.5%
HDL (mg/dL) 47.1 47.3 48.7 M, > 40mg/dL F, > 50mg/dL 52.5% 45.0% 55.0%
Triglycerides (mg/dL) 169.9 159.1 162.0 < 150mg/dL 62.5% 60.0% 55.0%
Weight (lbs) 207.4 211.1 208.5
BMI (kg/m2) 34.4 34.8 34.3 < 30 kg/m2 30.0% 25.0% 30.0%
Waist Circumference (in) 42.4 43.3 43.0 M, £ 40 inches F, £ 35 inches 22.5% 17.5% 25.0%
BMI, body mass index; DBP, diastolic blood pressure; F, female; HDL, high-density lipoprotein cholesterol; in, inches; LDL, low-density
lipoprotein cholesterol; M, male; SBP, systolic blood pressure.
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Depression is a known comorbidity with diabetes and was
assessed at baseline and 12-month follow-up with the PHQ-
2.18,19,20 The PHQ-2 score declined by 0.29 points on av-
erage from 1.0792 to 0.7980 (P = 0.0592); however, the
percent of participants with depression (PHQ-2 score greater
than or equal to 3) declined from 14.9% to 9.9%, which was
directionally important, but not statistically significant
(P = 0.1967) (Fig. 3).
Worker productivity (‘‘presenteeism’’) was assessed with
the 8-question Work Limitation Questionnaire. In this study,
3 domains (time management, interpersonal, and output)
were assessed with this questionnaire. Only the output do-
main change was statistically significant (P = 0.0412). There
was no change in the self-reported number of days missed
from work in the past 6 months related to diabetes.
Program attendance and evaluation
Almost all participants found this educational program to
be very helpful in imparting knowledge about their disease.
Participant responses were as follows: extremely helpful
(48.5%), very helpful (36.6%), somewhat helpful (13.9%);
only 1 respondent reported that it was ‘‘not very helpful or
valuable’’ (1.0%). Attendance at at least 1 of the additional
sessions was reported by 82.2% of participants and partic-
ipants attended an average of 2.7 additional sessions. The
FIG. 1. Knowledge of diabetes mellitus (DM) at pre program and 12-month follow-up (percentage responding excellent,
very good, or good) (N= 101).
FIG. 2. Diabetes care actions at pre program and 12-month follow-up (N= 101). DM, diabetes mellitus.
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vast majority of participants worked with a member of the
on-site clinical care team including a nurse or nurse prac-
titioner (88.1%), health coach (55.4%), registered dietitian
(72.3%), pharmacist (23.8%), and/or EAP counselor (7.9%).
Changes made associated with the program
Diabetics reported the following actions: saw a doctor
(31.7%); started on medication (5.9%); medication changed
by their doctor (15.8%); started an exercise program (53.5%);
lost weight (47.5%); quit or attempted to quit smoking (4%),
which was among all reported smokers; talked to an EAP
counselor (5.9%); other (7.9%).
Discussion
It should be anticipated that patients with diabetes who
received education and counseling would be more likely to
have improved glycemic, blood pressure, and hyperlipid-
emia control. However, studies have shown that patients in
general are not receiving the education and counseling they
need. This study evaluated the role a worksite diabetes
disease management program integrated with a workplace
occupational health clinic medical team had on biometrics
and disease knowledge for an employee population who was
at risk for diabetes, had prediabetes, or was diagnosed with
diabetes.
This study demonstrated significant improvement in em-
ployee knowledge of diabetes. However, biometrics in
general did not show a significant change in part because
diabetes was already relatively well controlled in this in-
sured employee population. Diabetic participants had a
mean baseline HbA1c level of 7.2% and generally well-
controlled blood pressure and blood lipid levels. The value-
based insurance design in a full replacement Consumer-
Directed Health Plan offered by this employer probably
contributed to these findings. Preventive care, including
annual physicals, were covered at 100% with no deductible
or co-payments. Generic prescription oral diabetes medica-
tions were available ‘‘free’’ to employees with no co-pay-
ments or insurance deductible.
There have been relatively few long-term studies evalu-
ating the effectiveness of diabetes self-management educa-
tion programs and the outcomes of these studies have
reported mixed results. Deakin et al reviewed a group-based
patient training of self-management strategies in type 2 di-
abetes and found they were effective in improving blood
glucose, blood pressure, body weight, and the need for an-
tidiabetic drugs.21,22 Khunti et al reported on a 3-year fol-
low-up of an education and self-management program for
people newly diagnosed with type 2 diabetes.23 This study
was conducted in 13 primary care sites in the United
Kingdom. The primary outcome was HbA1c levels. The
secondary outcomes included blood pressure, weight, blood
lipid levels, smoking status, physical activity, quality of life,
beliefs about illness, depression, emotional impact of dia-
betes, and drug use at 3 years. There was no statistically
significant difference at 3 years in HbA1c levels between the
intervention and nonintervention groups. Neither was there a
difference in other biometrics, lifestyle, depression, quality
of life, and drug use outcomes. However, the authors found
a significant improvement in 4 of 5 health beliefs at 3 years.
The intervention group had a greater understanding of
their illness and its seriousness and a better understanding
of their ability to affect the course of their disease. Sperl-
Hillen et al reported that individual health education and not
a group health education program for patients with sub-
optimally controlled diabetes resulted in better glycemic
control.24
Morrison et al reported on a retrospective analysis of
26,496 patients with diabetes and elevated HbA1c, blood
pressure, and/or LDL cholesterol treated by primary care
physicians at 2 teaching hospitals. Patients who saw their
primary care physician every 2 weeks achieved HbA1c,
blood pressure, and LDL cholesterol targets the fastest.25,26
Rasekba et al reported on the results of a diabetes disease
management program on diabetes control and patient quality
of life in 967 patients and 12-month follow-up in Australia.
Baseline HbA1c was 8.6% and was 7.3% at 12 months.
However, patients with diabetes in their study population
were, in general, not well controlled in contrast to the
FIG. 3. Diabetes and work-related outcomes (N = 101). PHQ-2, Patient Health Questionnaire-2.
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present study’s employee patient population, which had
good overall HbA1c control on average.27
There are a variety of reasons why patients with diabetes
are noncompliant, including nonadherence to medications.
Noncompliance could be because patients with diabetes also
may suffer from depression.28 Gonzalez et al reported that
19% of patients with type 2 diabetes probably suffered from
major depression and an additional 66% reported some
symptoms of depression.29 Patients with depression were
less adherent to diet, exercise, glucose self-monitoring and
medication adherence. Because depression and depressive
symptoms are associated with nonadherence, participants in
the present study were provided with both written materials
on depression and offered a webinar presented by a clinical
psychologist who is director of the firm’s EAP. Visits with
an EAP counselor were available at no cost to the employee
in each of the worksite occupational health clinics. Em-
ployees also can see an EAP provider in the community at
no cost for up to 8 visits.
Previous studies have examined the potential association
between reduced patient cost sharing with a value-based
benefit design and increased medication adherence in pa-
tients with diabetes.30,31,32 To address this concern, the
corporation initiated a value-based pharmacy benefit design
that provided free generic preventive medications for dia-
betes, hypertension, and hyperlipidemia. Insulin also was
added to the free preventive medication benefit. It is antic-
ipated that increased diabetes medication adherence would
result in decreased emergency department visits and hos-
pitalizations, less absenteeism and disability, and increased
on-the-job productivity related to better diabetes control.
The employee survey did find that the cost of diabetes
supplies for glucose self-monitoring may be a barrier to
glycemic control, indicating a benefit design issue that will
need to be addressed.
Researchers have examined other factors related to control
of diabetes. For example, Jameson et al reported on the benefit
of including a pharmacist in the management of diabetes.33 A
pharmacist was a member of the present study’s intervention
team and employees had access to individual consultations
with the pharmacist at no cost. Graco et al failed to find an
association between baseline psychological measures and
glycemic control in diabetes. In a study of 86 patientswith type
2 diabetes with an average baseline HbA1c of 8.9% indicating
poor control, improved control was associated with being seen
earlier in their disease course and more intense management
regardless of their psychometric status.34
Limitations
The study team acknowledges certain limitations that are
present in most worksite applied research studies. This was
not a randomized controlled study. Therefore, employees
who enrolled and completed the program may not represent
the entire population with diabetes for this employer. Their
diabetes may or may not be controlled to the same extent as
the entire employee population. This population may be
more motivated to control their diabetes than the general
diabetes population for the employer. Biometric testing in-
dicated that, on average, the diabetes in this study popula-
tion was controlled. It is unknown if this educational model
can be extrapolated to other employers with different types
of jobs, employee education level, or employee demo-
graphics. Longer term follow-up of this population is needed
to determine if the educational intervention learning is
sustainable.
The 12-month completion rate of this program was 40%
for those participants who completed the preprogram ques-
tionnaire. There were several reasons for dropout, including
36 individuals who were no longer employed by the con-
clusion of the program, and others who chose to discontinue
their participation. For the 92 employees who completed the
preprogram questionnaire but not the post-program ques-
tionnaire, their results indicate they had poorer control of
their diabetes than those who fully completed the program;
28 of those 92 employees participated in all 3 biometric
screenings, even though they did not complete the post-
program questionnaire. Biometric measurements for this
group showed mixed results with improvement in some
measures and maintenance in others. The research team is
unable to explain why employees who participated in the
majority of the program activities chose not to complete the
post-program questionnaire, and become eligible for a prize
raffle of an e-reader/tablet device. However, poor comple-
tion rates are a commonly reported problem in disease
management programs.35 Another challenge in this organi-
zation and many others is how to reach employees who
work remotely with programs such as these.
Conclusions
A 12-month worksite-based educational program for em-
ployees who were at risk for diabetes, had prediabetes, or were
diagnosed with diabetes statistically improved most self-
efficacy measures. However, this population generally had
acceptable control of their diabetes and there was no statisti-
cally significant improvement in biometric tests at 6 and
12 months. Worksite occupational medicine clinics staffed by
health professionals including a physician/nurse practitioner,
nurse, health coaches, dietician, consulting pharmacist, and
EAP counselor offer an important service in assisting em-
ployees with a variety of chronic diseases such as DM.
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